Literature DB >> 35493763

Thioredoxin and aging: What have we learned from the survival studies?

Madeline G Roman1, Lisa C Flores1, Geneva M Cunningham1, Christie Cheng1, Colton Allen1, Gene B Hubbard1,2, Yidong Bai3, Thomas L Saunders4, Yuji Ikeno1,2,5.   

Abstract

Our laboratory has conducted the first systematic survival studies to examine the biological effects of the antioxidant protein thioredoxin (Trx) on aging and age-related pathology. Our studies with C57BL/6 mice overexpressing Trx1 [Tg(act-TRX1)+/0 and Tg(TXN)+/0) demonstrated a slight extension in early lifespan compared to wild-type (WT) mice; however, no significant effects were observed in the later part of life. Overexpression of Trx2 in male C57BL/6 mice [Tg(TXN2)+/0] demonstrated a slightly extended lifespan compared to WT mice. The pathology results from two lines of Trx1 transgenic mice showed a slightly higher incidence of age-related neoplastic diseases compared to WT mice, and a slight increase in the severity of lymphoma, a major neoplastic disease, was observed in Trx2 transgenic mice. Together these studies indicate that Trx overexpression in one compartment of the cell (cytosol or mitochondria alone) has marginal beneficial effects on lifespan. On the other hand, down-regulation of Trx in either the cytosol (Trx1KO) or mitochondria (Trx2KO) showed no significant changes in lifespan compared to WT mice, despite several changes in pathophysiology of these knockout mice. When we examined the synergetic effects of overexpressing Trx1 and Trx2, TXNTg x TXN2Tg mice showed a significantly shorter lifespan with accelerated cancer development compared to WT mice. These results suggest that synergetic effects of Trx overexpression in both the cytosol and mitochondria on aging are deleterious and the development of age-related cancer is accelerated. On the other hand, we have recently found that down-regulation of Trx in both the cytosol and mitochondria in Trx1KO x Trx2KO mice has beneficial effects on aging. The results generated from our lab along with our ongoing study using Trx1KO x Trx2KO mice could elucidate the key pathways (i.e., apoptosis and autophagy) that prevent accumulation of damaged cells and genomic instability leading to reduced cancer formation.

Entities:  

Keywords:  Thioredoxin; aging; cancer; knockout mouse; lifespan; transgenic mouse

Year:  2020        PMID: 35493763      PMCID: PMC9049237          DOI: 10.31491/apt.2020.09.028

Source DB:  PubMed          Journal:  Aging Pathobiol Ther        ISSN: 2690-1803


  36 in total

Review 1.  Peptide methionine sulfoxide reductase: biochemistry and physiological role.

Authors:  N Brot; H Weissbach
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

2.  Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells.

Authors:  B P Zambrowicz; G A Friedrich; E C Buxton; S L Lilleberg; C Person; A T Sands
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

3.  Methionine residues may protect proteins from critical oxidative damage.

Authors:  R L Levine; B S Berlett; J Moskovitz; L Mosoni; E R Stadtman
Journal:  Mech Ageing Dev       Date:  1999-03-15       Impact factor: 5.432

4.  Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions.

Authors:  Haifeng Zhang; Yan Luo; Wei Zhang; Yun He; Shengchuan Dai; Rong Zhang; Yan Huang; Pascal Bernatchez; Frank J Giordano; Gerald Shadel; William C Sessa; Wang Min
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

5.  Lifespan decrease in a Caenorhabditis elegans mutant lacking TRX-1, a thioredoxin expressed in ASJ sensory neurons.

Authors:  Antonio Miranda-Vizuete; Juan Carlos Fierro González; Gabriele Gahmon; Jan Burghoorn; Plácido Navas; Peter Swoboda
Journal:  FEBS Lett       Date:  2005-12-22       Impact factor: 4.124

6.  Reduction in glutathione peroxidase 4 increases life span through increased sensitivity to apoptosis.

Authors:  Qitao Ran; Hanyu Liang; Yuji Ikeno; Wenbo Qi; Tomas A Prolla; L Jackson Roberts; Norman Wolf; Holly Van Remmen; Holly VanRemmen; Arlan Richardson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-09       Impact factor: 6.053

7.  Thioredoxin-2 affects lifespan and oxidative stress in Drosophila.

Authors:  Malin J Svensson; Jan Larsson
Journal:  Hereditas       Date:  2007-03       Impact factor: 3.271

8.  Enzymatic reduction of protein-bound methionine sulfoxide.

Authors:  N Brot; L Weissbach; J Werth; H Weissbach
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice.

Authors:  Larisa Nonn; Ryan R Williams; Robert P Erickson; Garth Powis
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  Continuous overexpression of thioredoxin 1 enhances cancer development and does not extend maximum lifespan in male C57BL/6 mice.

Authors:  Lisa C Flores; Madeline G Roman; Geneva M Cunningham; Christie Cheng; Sara Dube; Colton Allen; Holly Van Remmen; Gene B Hubbard; Thomas L Saunders; Yuji Ikeno
Journal:  Pathobiol Aging Age Relat Dis       Date:  2018-10-23
View more
  1 in total

Review 1.  Emerging Evidence of the Significance of Thioredoxin-1 in Hematopoietic Stem Cell Aging.

Authors:  Shaima Jabbar; Parker Mathews; Yubin Kang
Journal:  Antioxidants (Basel)       Date:  2022-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.